The DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR) and/or the HDAC inhibitor Trichostatin A (TSA) strongly upregulated the expression of Maspin in breast cancer and prostate cancer cells (42, 43). This evidence concerns the gene HDAC9 and breast carcinoma.